深度学习从筛查乳腺X线摄影预测筛查检出与间期乳腺癌:6369例病例-病例-对照研究
深度学习模型预测筛查检出癌风险的C统计量为0.66,与BI-RADS密度联合临床风险因素模型相当;但预测间期癌风险时C统计量仅0.64,低于BI-RADS密度联合临床风险因素模型的0.71。
要点
- 深度学习模型对筛查检出乳腺癌风险有一定区分能力,C统计量0.66,与BI-RADS密度联合临床风险因素模型相当。
- 深度学习模型对间期癌风险区分能力较低,C统计量0.64,低于BI-RADS密度联合临床风险因素模型的0.71。
- BI-RADS密度联合临床风险因素模型对间期癌的比值比为7.25,明显高于深度学习模型的1.26。
核心结论
- 深度学习模型在判断筛查检出乳腺癌风险方面表现优于临床风险因素,但在判断间期癌风险方面不如包含乳腺密度的临床风险因素模型。
研究设计与样本
- 深度学习模型在阴性筛查图像上训练,分类未发生癌症、筛查检出癌和间期浸润性癌,在占26%(1669/6369)的留出测试集中以匹配一致性统计量(C统计量)评估。
诊断标准与关键数值
- 筛查检出癌 vs 匹配对照:深度学习模型C统计量0.66(95%CI: 0.63, 0.69),比值比1.25(95%CI: 1.17, 1.33);BI-RADS密度联合临床风险因素模型C统计量0.62(95%CI: 0.59, 0.65),比值比2.14(95%CI: 1.32, 3.45);联合模型C统计量0.66(95%CI: 0.63, 0.69),比值比1.21(95%CI: 1.13, 1.30)。
- 间期癌 vs 对照:深度学习模型C统计量0.64(95%CI: 0.58, 0.71),比值比1.26(95%CI: 1.10, 1.45);BI-RADS密度(b级 vs 非b级)联合临床风险因素模型C统计量0.71(95%CI: 0.65, 0.77),比值比7.25(95%CI: 2.94, 17.9);联合模型C统计量0.72(95%CI: 0.66, 0.78),比值比1.10(95%CI: 0.94, 1.29)。
- 深度学习、BI-RADS密度和联合模型检测筛查癌与间期癌能力比较的P值分别为.99、.002和.03。
临床应用与阅片要点
- 深度学习模型可用于筛查检出乳腺癌的风险分层,但不能替代乳腺密度等临床风险因素对间期癌风险的评估。
- 阅片时对BI-RADS密度为b级的女性应警惕间期癌风险,该因素在临床风险因素模型中比值比达7.25。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The ability of deep learning (DL) models to classify women as at risk for either screening mammography-detected or interval cancer (not detected at mammography) has not yet been explored in the literature. Purpose To examine the ability of DL models to estimate the risk of interval and screening-detected breast cancers with and without clinical risk factors. Materials and Methods This study was performed on 25 096 digital screening mammograms obtained from January 2006 to December 2013. The mammograms were obtained in 6369 women without breast cancer, 1609 of whom developed screening-detected breast cancer and 351 of whom developed interval invasive breast cancer. A DL model was trained on the negative mammograms to classify women into those who did not develop cancer and those who developed screening-detected cancer or interval invasive cancer. Model effectiveness was evaluated as a matched concordance statistic (C statistic) in a held-out 26% (1669 of 6369) test set of the mammograms. Results The C statistics and odds ratios for comparing patients with screening-detected cancer versus matched controls were 0.66 (95% CI: 0.63, 0.69) and 1.25 (95% CI: 1.17, 1.33), respectively, for the DL model, 0.62 (95% CI: 0.59, 0.65) and 2.14 (95% CI: 1.32, 3.45) for the clinical risk factors with the Breast Imaging Reporting and Data System (BI-RADS) density model, and 0.66 (95% CI: 0.63, 0.69) and 1.21 (95% CI: 1.13, 1.30) for the combined DL and clinical risk factors model. For comparing patients with interval cancer versus controls, the C statistics and odds ratios were 0.64 (95% CI: 0.58, 0.71) and 1.26 (95% CI: 1.10, 1.45), respectively, for the DL model, 0.71 (95% CI: 0.65, 0.77) and 7.25 (95% CI: 2.94, 17.9) for the risk factors with BI-RADS density (b rated vs non-b rated) model, and 0.72 (95% CI: 0.66, 0.78) and 1.10 (95% CI: 0.94, 1.29) for the combined DL and clinical risk factors model. The P values between the DL, BI-RADS, and combined model's ability to detect screen and interval cancer were .99, .002, and .03, respectively. Conclusion The deep learning model outperformed in determining screening-detected cancer risk but underperformed for interval cancer risk when compared with clinical risk factors including breast density. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Bae and Kim in this issue.
引用
- Zhu X, Wolfgruber TK, Leong L, et al. Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women. Radiology. 2021. PMID: 34491131. doi:10.1148/radiol.2021203758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。